<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35725310</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1673-0860</ISSN><JournalIssue CitedMedium="Print"><Volume>57</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>07</Day></PubDate></JournalIssue><Title>Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery</Title><ISOAbbreviation>Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Analysis of relationship between distribution of pathogenic microorganisms in olfactory cleft and olfactory disorders among patients with upper respiratory inflammation during the prevention and control of COVID-19].</ArticleTitle><Pagination><StartPage>683</StartPage><EndPage>691</EndPage><MedlinePgn>683-691</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn115330-20210727-00490</ELocationID><Abstract><AbstractText><b>Objective:</b> To explore the relationship between pathogens in the olfactory cleft area and olfactory disorders in patients with upper respiratory inflammation (URI) during the prevention and control of 2019 novel coronavirus disease (COVID-19). <b>Methods:</b> A total of 234 URI patients including acute upper respiratory infection, chronic rhinosinusitis (CRS), allergic rhinitis (AR) were continuously selected from September 2020 to March 2021 in Beijing Anzhen Hospital and 98 healthy adults were enrolled as controls. The secretions from the olfactory cleft of all subjects were collected with nasal swabs under nasal endoscopy. Multiple real-time fluorescent quantitative polymerase chain reaction detection method was used to detect nucleic acids of 33 types of respiratory pathogenic microorganism. Sniffin' Sticks olfactory test was performed on all patients with URI. URI patients with olfactory dysfunction were followed up for 9 (8, 10) months (<i>M</i> (<i>Q</i><sub>1</sub>, <i>Q</i><sub>3</sub>)). SPSS 20.0 software was used for statistical analysis. <b>Results:</b> Among the 98 controls, 9 (9.18%) were positive for pathogenic microorganisms, including 1 (1.02%) rhinovirus, 1 (1.02%) parainfluenza virus type 3, 3 (3.06%) enterovirus, 1 (1.02%) staphylococcus aureus and 3 (3.06%) Moraxella catarrhalis. Among the 234 URI patients, 111 (47.44%) had olfactory disorders and 123 (52.56%) had normal sense of smell. In the olfactory disorder group (111 cases), 38 cases (34.23%) were positive for pathogenic microorganisms, and 4 cases (3.60%) were mixed infection, including 11 cases of rhinovirus (9.91%), 5 cases of coronavirus 229E (4.50%), 2 cases of coronavirus OC43/NL63 (1.80%), 3 cases of parainfluenza virus type 1 (2.70%), 2 cases of enterovirus (1.80%), 1 case of influenza B virus type BV (0.90%), 11 cases of Staphylococcus aureus (9.91%), 7 cases of Moraxella catarrhalis (6.31%), and 1 case of Klebsiella pneumoniae (0.90%). In the normal smell group (123 cases), 18 cases (14.63%) were positive for pathogenic microorganisms, and 1 case (0.81%) was mixed infection, including 3 cases of rhinovirus (2.44%), 4 cases of coronavirus 229E (3.25%), 1 case of Influenza virus type 3 (0.81%), 3 cases of enterovirus (2.44%), 3 cases of Staphylococcus aureus (2.44%), 4 cases of Moraxella catarrhalis (3.25%), and 1 case of Klebsiella pneumoniae (0.81%). Univariate analysis between the two groups found that there were significant differences in the detection rate of pathogenic microorganisms, rhinovirus and Staphylococcus aureus between the groups (all <i>P</i>&lt;0.05). The detection rate of parainfluenza virus type 1, Staphylococcus aureus, and rhinovirus were different between the patients with olfactory disorder and normal olfactory function in the three subgroups of acute upper respiratory tract infection, CRS and AR, respectively (&#x3c7;<i><sup>2</sup></i> value was 3.88, 4.53 and 4.73, respectively, all <i>P</i>&lt;0.05). During the follow-up period, among the 111 patients with olfactory disorder, 71 (63.96%) patients' olfactory function returned to normal, 32 (28.83%) patients' olfactory function improved but not completely returned to normal, 8 (7.21%) patients' olfactory function did not improve. <b>Conclusions:</b> During the prevention and control of COVID-19, rhinovirus or Staphylococcus aureus infection or colonization of URI patients is closely related to olfactory disorders. Parainfluenza virus type 1 infection can cause relatively persistent olfactory disorders in patients with acute upper respiratory tract infection. Staphylococcus aureus and rhinovirus colonization are related to the occurrence of olfactory dysfunction in CRS and AR patients respectively.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>L C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology Head and Neck Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>H L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Key Laboratory of Upper Airway Dysfunction, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Y R</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>Key Laboratory of Upper Airway Dysfunction, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>F F</ForeName><Initials>FF</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology Head and Neck Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>J W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology Head and Neck Surgery, the First Affiliated Hospital of USTC (Anhui Provincial Hospital), Hefei 230026, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Y X</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology Head and Neck Surgery, Capital Institute of Pediatrics, Beijing 100020, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>81670903</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi</MedlineTA><NlmUniqueID>101247574</NlmUniqueID><ISSNLinking>1673-0860</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012852" MajorTopicYN="Y">Sinusitis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012903" MajorTopicYN="N">Smell</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>&#x76ee;&#x7684;&#xff1a;</b> &#x63a2;&#x7d22;&#x9632;&#x63a7;&#x65b0;&#x578b;&#x51a0;&#x72b6;&#x75c5;&#x6bd2;&#x75c5;&#xff08;2019 novel coronavirus disease&#xff0c;COVID-19&#xff09;&#x671f;&#x95f4;&#x4e0a;&#x547c;&#x5438;&#x9053;&#x708e;&#x75c7;&#xff08;upper respiratory inflammation&#xff0c;URI&#xff09;&#x60a3;&#x8005;&#x7684;&#x55c5;&#x533a;&#x75c5;&#x539f;&#x5fae;&#x751f;&#x7269;&#x5206;&#x5e03;&#x4e0e;&#x55c5;&#x89c9;&#x969c;&#x788d;&#x7684;&#x5173;&#x7cfb;&#x3002; <b>&#x65b9;&#x6cd5;&#xff1a;</b> &#x8fde;&#x7eed;&#x6027;&#x6536;&#x96c6;2020&#x5e74;9&#x6708;&#x81f3;2021&#x5e74;3&#x6708;&#x5c31;&#x8bca;&#x4e8e;&#x5317;&#x4eac;&#x5b89;&#x8d1e;&#x533b;&#x9662;&#x5305;&#x62ec;&#x6025;&#x6027;&#x4e0a;&#x547c;&#x5438;&#x9053;&#x611f;&#x67d3;&#x3001;&#x6162;&#x6027;&#x9f3b;&#x7aa6;&#x708e;&#xff08;CRS&#xff09;&#x3001;&#x53d8;&#x5e94;&#x6027;&#x9f3b;&#x708e;&#xff08;AR&#xff09;&#x5728;&#x5185;&#x7684;URI&#x60a3;&#x8005;234&#x4f8b;&#xff0c;&#x5065;&#x5eb7;&#x6210;&#x4eba;98&#x540d;&#x7eb3;&#x5165;&#x5bf9;&#x7167;&#x7ec4;&#x3002;&#x6240;&#x6709;&#x53d7;&#x8bd5;&#x8005;&#x5747;&#x5728;&#x9f3b;&#x5185;&#x955c;&#x4e0b;&#x7528;&#x9f3b;&#x62ed;&#x5b50;&#x91c7;&#x96c6;&#x55c5;&#x533a;&#x5206;&#x6ccc;&#x7269;&#xff0c;&#x91c7;&#x7528;&#x591a;&#x91cd;&#x5b9e;&#x65f6;&#x8367;&#x5149;&#x5b9a;&#x91cf;&#x805a;&#x5408;&#x9176;&#x94fe;&#x53cd;&#x5e94;&#x6cd5;&#x5bf9;33&#x79cd;/&#x578b;&#x547c;&#x5438;&#x9053;&#x75c5;&#x539f;&#x5fae;&#x751f;&#x7269;&#x8fdb;&#x884c;&#x6838;&#x9178;&#x68c0;&#x6d4b;&#x3002;URI&#x60a3;&#x8005;&#x5747;&#x884c;Sniffin&#x2032; Sticks&#x55c5;&#x89c9;&#x6d4b;&#x8bd5;&#x3002;&#x5bf9;URI&#x4f34;&#x55c5;&#x89c9;&#x969c;&#x788d;&#x60a3;&#x8005;&#x8fdb;&#x884c;&#x7535;&#x8bdd;&#x968f;&#x8bbf;&#xff0c;&#x968f;&#x8bbf;&#x65f6;&#x95f4;9&#xff08;8&#xff0c;10&#xff09;&#x4e2a;&#x6708;&#xff3b;<i>M</i>&#xff08;<i>Q</i><sub>1</sub>&#xff0c;<i>Q</i><sub>3</sub>&#xff09;&#xff3d;&#x3002;&#x91c7;&#x7528;SPSS 20.0&#x8f6f;&#x4ef6;&#x8fdb;&#x884c;&#x7edf;&#x8ba1;&#x5b66;&#x5206;&#x6790;&#x3002; <b>&#x7ed3;&#x679c;&#xff1a;</b> 98&#x540d;&#x5bf9;&#x7167;&#x7ec4;&#x4e2d;&#x75c5;&#x539f;&#x5fae;&#x751f;&#x7269;&#x9633;&#x6027;&#x8005;9&#x540d;&#xff08;9.18%&#xff09;&#xff0c;&#x5176;&#x4e2d;&#x9f3b;&#x75c5;&#x6bd2;1&#x540d;&#xff08;1.02%&#xff09;&#x3001;&#x526f;&#x6d41;&#x611f;&#x75c5;&#x6bd2;3&#x578b;1&#x540d;&#xff08;1.02%&#xff09;&#x3001;&#x80a0;&#x9053;&#x75c5;&#x6bd2;3&#x540d;&#xff08;3.06%&#xff09;&#x3001;&#x91d1;&#x9ec4;&#x8272;&#x8461;&#x8404;&#x7403;&#x83cc;1&#x540d;&#xff08;1.02%&#xff09;&#x3001;&#x5361;&#x4ed6;&#x83ab;&#x62c9;&#x83cc;3&#x540d;&#xff08;3.06%&#xff09;&#x3002;234&#x4f8b;URI&#x60a3;&#x8005;&#x4e2d;&#x55c5;&#x89c9;&#x969c;&#x788d;&#x8005;111&#x4f8b;&#xff08;47.44%&#xff09;&#x3001;&#x55c5;&#x89c9;&#x6b63;&#x5e38;&#x8005;123&#x4f8b;&#xff08;52.56%&#xff09;&#x3002;&#x55c5;&#x89c9;&#x969c;&#x788d;&#x7ec4;&#xff08;111&#x4f8b;&#xff09;&#x75c5;&#x539f;&#x5fae;&#x751f;&#x7269;&#x9633;&#x6027;&#x8005;38&#x4f8b;&#xff08;34.23%&#xff09;&#xff0c;&#x6df7;&#x5408;&#x611f;&#x67d3;&#x8005;4&#x4f8b;&#xff08;3.60%&#xff09;&#xff0c;&#x5176;&#x4e2d;&#x9f3b;&#x75c5;&#x6bd2;11&#x4f8b;&#xff08;9.91%&#xff09;&#x3001;&#x51a0;&#x72b6;&#x75c5;&#x6bd2;229E 5&#x4f8b;&#xff08;4.50%&#xff09;&#x3001;&#x51a0;&#x72b6;&#x75c5;&#x6bd2;OC43/NL63 2&#x4f8b;&#xff08;1.80%&#xff09;&#x3001;&#x526f;&#x6d41;&#x611f;&#x75c5;&#x6bd2;1&#x578b;3&#x4f8b;&#xff08;2.70%&#xff09;&#x3001;&#x80a0;&#x9053;&#x75c5;&#x6bd2;2&#x4f8b;&#xff08;1.80%&#xff09;&#x3001;&#x4e59;&#x578b;&#x6d41;&#x611f;&#x75c5;&#x6bd2;BV&#x7cfb;1&#x4f8b;&#xff08;0.90%&#xff09;&#x3001;&#x91d1;&#x9ec4;&#x8272;&#x8461;&#x8404;&#x7403;&#x83cc;11&#x4f8b;&#xff08;9.91%&#xff09;&#x3001;&#x5361;&#x4ed6;&#x83ab;&#x62c9;&#x83cc;7&#x4f8b;&#xff08;6.31%&#xff09;&#x3001;&#x80ba;&#x708e;&#x514b;&#x96f7;&#x4f2f;&#x83cc;1&#x4f8b;&#xff08;0.90%&#xff09;&#x3002;&#x55c5;&#x89c9;&#x6b63;&#x5e38;&#x7ec4;&#xff08;123&#x4f8b;&#xff09;&#x75c5;&#x539f;&#x5fae;&#x751f;&#x7269;&#x9633;&#x6027;&#x8005;18&#x4f8b;&#xff08;14.63%&#xff09;&#xff0c;&#x6df7;&#x5408;&#x611f;&#x67d3;&#x8005;1&#x4f8b;&#xff08;0.81%&#xff09;&#xff0c;&#x5176;&#x4e2d;&#x9f3b;&#x75c5;&#x6bd2;3&#x4f8b;&#xff08;2.44%&#xff09;&#x3001;&#x51a0;&#x72b6;&#x75c5;&#x6bd2;229E 4&#x4f8b;&#xff08;3.25%&#xff09;&#x3001;&#x526f;&#x6d41;&#x611f;&#x75c5;&#x6bd2;3&#x578b;1&#x4f8b;&#xff08;0.81%&#xff09;&#x3001;&#x80a0;&#x9053;&#x75c5;&#x6bd2;3&#x4f8b;&#xff08;2.44%&#xff09;&#x3001;&#x91d1;&#x9ec4;&#x8272;&#x8461;&#x8404;&#x7403;&#x83cc;3&#x4f8b;&#xff08;2.44%&#xff09;&#x3001;&#x5361;&#x4ed6;&#x83ab;&#x62c9;&#x83cc;4&#x4f8b;&#xff08;3.25%&#xff09;&#x3001;&#x80ba;&#x708e;&#x514b;&#x96f7;&#x4f2f;&#x83cc;1&#x4f8b;&#xff08;0.81%&#xff09;&#x3002;&#x4e24;&#x7ec4;&#x95f4;&#x5355;&#x56e0;&#x7d20;&#x5206;&#x6790;&#x53d1;&#x73b0;&#xff0c;&#x75c5;&#x539f;&#x5fae;&#x751f;&#x7269;&#x68c0;&#x51fa;&#x7387;&#x3001;&#x9f3b;&#x75c5;&#x6bd2;&#x548c;&#x91d1;&#x9ec4;&#x8272;&#x8461;&#x8404;&#x7403;&#x83cc;&#x68c0;&#x51fa;&#x7387;&#x7684;&#x7ec4;&#x95f4;&#x5dee;&#x5f02;&#x5747;&#x5b58;&#x5728;&#x7edf;&#x8ba1;&#x5b66;&#x610f;&#x4e49;&#xff08;<i>P</i>&#x503c;&#x5747;<i>&lt;</i>0.05&#xff09;&#x3002;&#x526f;&#x6d41;&#x611f;&#x75c5;&#x6bd2;1&#x578b;&#x3001;&#x91d1;&#x9ec4;&#x8272;&#x8461;&#x8404;&#x7403;&#x83cc;&#x3001;&#x9f3b;&#x75c5;&#x6bd2;&#x68c0;&#x51fa;&#x7387;&#x5206;&#x522b;&#x5728;&#x6025;&#x6027;&#x4e0a;&#x547c;&#x5438;&#x9053;&#x611f;&#x67d3;&#x3001;CRS&#x548c;AR 3&#x4e2a;&#x4e9a;&#x7ec4;&#x7684;&#x55c5;&#x89c9;&#x969c;&#x788d;&#x548c;&#x55c5;&#x89c9;&#x6b63;&#x5e38;&#x8005;&#x4e2d;&#x5b58;&#x5728;&#x5dee;&#x5f02;&#xff08;&#x3c7;<i><sup>2</sup></i>&#x503c;&#x5206;&#x522b;&#x4e3a;3.88&#x3001;4.53&#x548c;4.73&#xff0c;<i>P</i>&#x503c;&#x5747;&lt;0.05&#xff09;&#x3002;&#x968f;&#x8bbf;&#x671f;&#x95f4;&#xff0c;111&#x4f8b;&#x55c5;&#x89c9;&#x969c;&#x788d;&#x60a3;&#x8005;&#x4e2d;&#xff0c;&#x55c5;&#x89c9;&#x529f;&#x80fd;&#x5b8c;&#x5168;&#x6062;&#x590d;&#x6b63;&#x5e38;&#x8005;71&#x4f8b;&#xff08;63.96%&#xff09;&#xff0c;&#x55c5;&#x89c9;&#x529f;&#x80fd;&#x6539;&#x5584;&#x4f46;&#x672a;&#x8fbe;&#x5b8c;&#x5168;&#x6b63;&#x5e38;&#x8005;32&#x4f8b;&#xff08;28.83%&#xff09;&#xff0c;&#x55c5;&#x89c9;&#x529f;&#x80fd;&#x65e0;&#x6539;&#x5584;&#x8005;8&#x4f8b;&#xff08;7.21%&#xff09;&#x3002; <b>&#x7ed3;&#x8bba;&#xff1a;</b> &#x9632;&#x63a7;COVID-19&#x671f;&#x95f4;&#xff0c;URI&#x60a3;&#x8005;&#x55c5;&#x533a;&#x9f3b;&#x75c5;&#x6bd2;&#x6216;&#x91d1;&#x9ec4;&#x8272;&#x8461;&#x8404;&#x7403;&#x83cc;&#x611f;&#x67d3;&#x6216;&#x5b9a;&#x690d;&#x4e0e;&#x55c5;&#x89c9;&#x969c;&#x788d;&#x7684;&#x53d1;&#x751f;&#x5bc6;&#x5207;&#x76f8;&#x5173;&#x3002;&#x526f;&#x6d41;&#x611f;&#x75c5;&#x6bd2;1&#x578b;&#x611f;&#x67d3;&#x53ef;&#x9020;&#x6210;&#x6025;&#x6027;&#x4e0a;&#x547c;&#x5438;&#x9053;&#x611f;&#x67d3;&#x60a3;&#x8005;&#x76f8;&#x5bf9;&#x6301;&#x4e45;&#x7684;&#x55c5;&#x89c9;&#x969c;&#x788d;&#x3002;&#x91d1;&#x9ec4;&#x8272;&#x8461;&#x8404;&#x7403;&#x83cc;&#x3001;&#x9f3b;&#x75c5;&#x6bd2;&#x7684;&#x5b9a;&#x690d;&#x5206;&#x522b;&#x4e0e;CRS&#x548c;AR&#x60a3;&#x8005;&#x53d1;&#x751f;&#x55c5;&#x89c9;&#x969c;&#x788d;&#x6709;&#x5173;&#x3002;.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>20</Day><Hour>23</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35725310</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn115330-20210727-00490</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>